Atul Pande's Net Worth

Atul Pande's net worth is estimated to be at least $5,376,036.36 as of 12/23/2024. CoreStreet's estimation of Atul Pande's net worth is based on their sale of stock and current holding of stock.

Atul Pande is Director at Karuna Therapeutics Inc. They have executed at least 20 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,500 units of KRTX stock on 02/01/2022. Their biggest sale was on 12/14/2020 when they sold 5,714 units of Karuna Therapeutics Inc stock for $529,344.96. They typically trade 5 times per year.

Total value of insider buys:
  • $125,991.40
Total value of insider sells:
  • $5,250,044.96
Most recent insider trade:
  • Feb. 1, 2022

Atul Pande's Insider Trading History

Karuna Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 1, 2022
Director2,500$110.80Sell$277,000.00
Jan. 3, 2022
Director2,500$130.44Sell$326,100.00
Dec. 1, 2021
Director2,500$127.73Sell$319,325.00
Oct. 1, 2021
Director2,500$120.72Sell$301,800.00
Sept. 1, 2021
Director2,500$117.82Sell$294,550.00
Aug. 2, 2021
Director2,500$114.17Sell$285,425.00
June 1, 2021
Director2,500$111.44Sell$278,600.00
May 3, 2021
Director2,500$110.61Sell$276,525.00
April 1, 2021
Director2,500$120.01Sell$300,025.00
Feb. 1, 2021
Director2,500$100.00Sell$250,000.00
Dec. 14, 2020
Director5,714$92.64Sell$529,344.96
Nov. 12, 2020
Director5,000$96.84Sell$484,200.00
Nov. 3, 2020
Director5,000$85.00Sell$425,000.00
Sept. 16, 2020
Director5,000$85.00Sell$425,000.00
July 13, 2020
Director5,000$95.43Sell$477,150.00
Immunovant IncTitleAmountPriceTypeTotal Value
Aug. 13, 2021
Director5,000$7.98Buy$39,900.00
Sio Gene Therapies IncTitleAmountPriceTypeTotal Value
Nov. 24, 2020
Director10,000$2.34Buy$23,400.00
July 8, 2020
Director10,000$2.73Buy$27,300.00
March 16, 2020
Director10,000$1.78Buy$17,800.00
June 14, 2019
Director3,370$5.22Buy$17,591.40